재택치료 모니터링 및 케어 기술 시장 규모, 점유율 및 동향 분석 보고서 : 기술별, 용도별, 지역별 및 부문별 전망(2026-2033년)

Hospital-at-Home Monitoring & Care Technologies Market Summary

The global hospital-at-home monitoring & care technologies market size was valued at USD 25.2 billion in 2025 and is projected to grow from USD 27.8 billion in 2026 to USD 59.3 billion by 2033, at a CAGR of 11.4% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 40.4% in 2025. This growth is attributed to the growing need to reduce hospital bed pressure, rising adoption of remote monitoring and connected care technologies, and increasing demand for cost-efficient acute care delivery at home.

Global Hospital-at-Home Monitoring & Care Technologies Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global hospital-at-home monitoring & care technologiesmarket report based on technology, end use, and regions.

• Technology Outlook (Revenue, USD Billion, 2021 - 2033)
• Monitoring Technologies
  • Multiparameter Patient Monitors
  • Pulse Oximeters
  • ECG Monitors
  • Blood Pressure Monitors
  • Temperature Monitors
  • Respiratory Rate Monitors
  • Wearable Patient Monitors
  • Continuous Monitoring Patches
• Respiratory Care Technologies
  • Positive Airway Pressure (PAP) Devices
  • Non-Invasive Ventilation Devices
  • Invasive Ventilation Devices
  • Oxygen Concentrators
  • Nebulizers
• Digital Care Technologies
  • RPM Platforms
  • Virtual Nursing Platforms
  • Telehealth & Platforms
  • Clinical Alert & Escalation Systems
  • AI-Based Deterioration Prediction
  • Patient Engagement Platforms
• End Use Outlook (Revenue, USD Billion, 2021 - 2033)
• Hospitals
• Home Healthcare Providers
• Specialty Clinics
• Other
• Regional Outlook (Revenue, USD Billion, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Technology
  • 1.2.2. End use
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Growing Need to Reduce Hospital Bed Pressure
    • 3.2.1.2. Rising Adoption of Remote Monitoring and Connected Care Technologies
    • 3.2.1.3. Increasing Demand for Cost-Efficient Acute Care Delivery at Home
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High Technology and Implementation Costs
    • 3.2.2.2. Data Privacy, Cybersecurity, and Interoperability Challenges
  • 3.2.3. Industry Opportunity Analysis
  • 3.2.4. Industry Challenge Analysis
• 3.3. Technology Overview
  • 3.3.1. Integration and Interoperability
  • 3.3.2. Role of AI
  • 3.3.3. Smart Infrastructure
• 3.4. Regulatory Overview
• 3.5. Hospital at home model overview
• 3.6. Business Environment Analysis
  • 3.6.1. Porter's Five Forces Analysis
    • 3.6.1.1. Supplier power
    • 3.6.1.2. Buyer power
    • 3.6.1.3. Substitution threat
    • 3.6.1.4. Threat of new entrant
    • 3.6.1.5. Competitive rivalry
  • 3.6.2. PESTLE Analysis
    • 3.6.2.1. Political landscape
    • 3.6.2.2. Economic and Social landscape
    • 3.6.2.3. Technological landscape
    • 3.6.2.4. Environmental landscape
    • 3.6.2.5. Legal Landscape

Chapter 4. Hospital-at-Home Monitoring & Care Technologies Market: Technology Estimates & Trend Analysis

• 4.1. Technology Segment Dashboard
• 4.2. Technology Market Share Movement Analysis, 2025 & 2033
• 4.3. Market Size & Forecasts and Trend Analysis, by Technology, 2021 to 2033 (USD Billion)
• 4.4. Monitoring Technologies
  • 4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.4.2. Multiparameter Patient Monitors
    • 4.4.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.4.3. Pulse Oximeters
    • 4.4.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.4.4. ECG Monitors
    • 4.4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.4.5. Blood Pressure Monitors
    • 4.4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.4.6. Temperature Monitors
    • 4.4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.4.7. Respiratory Rate Monitors
    • 4.4.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.4.8. Wearable Patient Monitors
    • 4.4.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.4.9. Continuous Monitoring Patches
    • 4.4.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 4.5. Respiratory Care Technologies
  • 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.5.2. Positive Airway Pressure (PAP) Devices
    • 4.5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.5.3. Non-Invasive Ventilation Devices
    • 4.5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.5.4. Invasive Ventilation Devices
    • 4.5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.5.5. Oxygen Concentrators
    • 4.5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.5.6. Nebulizers
    • 4.5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 4.6. Digital Care Technologies
  • 4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.6.2. RPM Platforms
    • 4.6.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.6.3. Virtual Nursing Platforms
    • 4.6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.6.4. Telehealth & Platforms
    • 4.6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.6.5. Clinical Alert & Escalation Systems
    • 4.6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.6.6. AI-Based Deterioration Prediction
    • 4.6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.6.7. Patient Engagement Platforms
    • 4.6.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 5. Hospital-at-Home Monitoring & Care Technologies Market: End Use Estimates & Trend Analysis

• 5.1. End use Segment Dashboard
• 5.2. End use Market Share Movement Analysis, 2025 & 2033
• 5.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Billion)
• 5.4. Hospitals
  • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 5.5. Home Healthcare Providers
  • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 5.6. Specialty Clinics
  • 5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 5.7. Other
  • 5.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 6. Hospital-at-Home Monitoring & Care Technologies Market: Regional Estimates & Trend Analysis

• 6.1. Regional Market Dashboard
• 6.2. Regional Market: Key Takeaways
• 6.3. North America
  • 6.3.1. North America hospital-at-home monitoring & care technologies market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 6.3.2. U.S.
    • 6.3.2.1. Key country dynamic
    • 6.3.2.2. Regulatory framework
    • 6.3.2.3. Competitive insights
    • 6.3.2.4. U.S. hospital-at-home monitoring & care technologies market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 6.3.3. Canada
    • 6.3.3.1. Key country dynamic
    • 6.3.3.2. Regulatory framework
    • 6.3.3.3. Competitive insights
    • 6.3.3.4. Canada hospital-at-home monitoring & care technologies market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 6.3.4. Mexico
    • 6.3.4.1. Key country dynamic
    • 6.3.4.2. Regulatory framework
    • 6.3.4.3. Competitive insights
    • 6.3.4.4. Mexico hospital-at-home monitoring & care technologies market estimates and forecasts, 2021 - 2033 (USD Billion)
• 6.4. Europe
  • 6.4.1. Europe hospital-at-home monitoring & care technologies market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 6.4.2. Germany
    • 6.4.2.1. Key country dynamic
    • 6.4.2.2. Regulatory framework
    • 6.4.2.3. Competitive insights
    • 6.4.2.4. Germany hospital-at-home monitoring & care technologies market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 6.4.3. UK
    • 6.4.3.1. Key country dynamic
    • 6.4.3.2. Regulatory framework
    • 6.4.3.3. Competitive insights
    • 6.4.3.4. UK hospital-at-home monitoring & care technologies market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 6.4.4. France
    • 6.4.4.1. Key country dynamic
    • 6.4.4.2. Regulatory framework
    • 6.4.4.3. Competitive insights
    • 6.4.4.4. France hospital-at-home monitoring & care technologies market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 6.4.5. Italy
    • 6.4.5.1. Key country dynamic
    • 6.4.5.2. Regulatory framework
    • 6.4.5.3. Competitive insights
    • 6.4.5.4. Italy hospital-at-home monitoring & care technologies market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 6.4.6. Spain
    • 6.4.6.1. Key country dynamic
    • 6.4.6.2. Regulatory framework
    • 6.4.6.3. Competitive insights
    • 6.4.6.4. Spain hospital-at-home monitoring & care technologies market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 6.4.7. Denmark
    • 6.4.7.1. Key country dynamic
    • 6.4.7.2. Regulatory framework
    • 6.4.7.3. Competitive insights
    • 6.4.7.4. Denmark hospital-at-home monitoring & care technologies market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 6.4.8. Sweden
    • 6.4.8.1. Key country dynamic
    • 6.4.8.2. Regulatory framework
    • 6.4.8.3. Competitive insights
    • 6.4.8.4. Sweden hospital-at-home monitoring & care technologies market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 6.4.9. Norway
    • 6.4.9.1. Key country dynamic
    • 6.4.9.2. Regulatory framework
    • 6.4.9.3. Competitive insights
    • 6.4.9.4. Norway hospital-at-home monitoring & care technologies market estimates and forecasts, 2021 - 2033 (USD Billion)
• 6.5. Asia Pacific
  • 6.5.1. Asia Pacific hospital-at-home monitoring & care technologies market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 6.5.2. Japan
    • 6.5.2.1. Key country dynamic
    • 6.5.2.2. Regulatory framework
    • 6.5.2.3. Competitive insights
    • 6.5.2.4. Japan hospital-at-home monitoring & care technologies market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 6.5.3. China
    • 6.5.3.1. Key country dynamic
    • 6.5.3.2. Regulatory framework
    • 6.5.3.3. Competitive insights
    • 6.5.3.4. China hospital-at-home monitoring & care technologies market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 6.5.4. India
    • 6.5.4.1. Key country dynamic
    • 6.5.4.2. Regulatory framework
    • 6.5.4.3. Competitive insights
    • 6.5.4.4. India hospital-at-home monitoring & care technologies market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 6.5.5. South Korea
    • 6.5.5.1. Key country dynamic
    • 6.5.5.2. Regulatory framework
    • 6.5.5.3. Competitive insights
    • 6.5.5.4. South Korea hospital-at-home monitoring & care technologies market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 6.5.6. Australia
    • 6.5.6.1. Key country dynamic
    • 6.5.6.2. Regulatory framework
    • 6.5.6.3. Competitive insights
    • 6.5.6.4. Australia hospital-at-home monitoring & care technologies market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 6.5.7. Thailand
    • 6.5.7.1. Key country dynamic
    • 6.5.7.2. Regulatory framework
    • 6.5.7.3. Competitive insights
    • 6.5.7.4. Thailand hospital-at-home monitoring & care technologies market estimates and forecasts, 2021 - 2033 (USD Billion)
• 6.6. Latin America
  • 6.6.1. Latin America Hospital-at-Home Monitoring & Care Technologies Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 6.6.2. Brazil
    • 6.6.2.1. Key country dynamic
    • 6.6.2.2. Regulatory framework
    • 6.6.2.3. Competitive insights
    • 6.6.2.4. Brazil hospital-at-home monitoring & care technologies market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 6.6.3. Argentina
    • 6.6.3.1. Key country dynamic
    • 6.6.3.2. Regulatory framework
    • 6.6.3.3. Competitive insights
    • 6.6.3.4. Argentina hospital-at-home monitoring & care technologies market estimates and forecasts, 2021 - 2033 (USD Billion)
• 6.7. MEA
  • 6.7.1. MEA hospital-at-home monitoring & care technologies market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 6.7.2. South Africa
    • 6.7.2.1. Key country dynamic
    • 6.7.2.2. Regulatory framework
    • 6.7.2.3. Competitive insights
    • 6.7.2.4. South Africa hospital-at-home monitoring & care technologies market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 6.7.3. Saudi Arabia
    • 6.7.3.1. Key country dynamic
    • 6.7.3.2. Regulatory framework
    • 6.7.3.3. Competitive insights
    • 6.7.3.4. Saudi Arabia hospital-at-home monitoring & care technologies market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 6.7.4. UAE
    • 6.7.4.1. Key country dynamic
    • 6.7.4.2. Regulatory framework
    • 6.7.4.3. Competitive insights
    • 6.7.4.4. UAE hospital-at-home monitoring & care technologies market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 6.7.5. Kuwait
    • 6.7.5.1. Key country dynamic
    • 6.7.5.2. Regulatory framework
    • 6.7.5.3. Competitive insights
    • 6.7.5.4. Kuwait hospital-at-home monitoring & care technologies market estimates and forecasts, 2021 - 2033 (USD Billion)

Chapter 7. Competitive Landscape

• 7.1. Participant Overview
• 7.2. Company Market Position/Share Analysis, 2025
• 7.3. Company Categorization
• 7.4. Company Profiles/Listing
  • 7.4.1. Medtronic
    • 7.4.1.1. Overview
    • 7.4.1.2. Financial performance
    • 7.4.1.3. Product benchmarking
    • 7.4.1.4. Strategic initiatives
  • 7.4.2. GE HealthCare Technologies Inc.
    • 7.4.2.1. Overview
    • 7.4.2.2. Financial performance
    • 7.4.2.3. Product benchmarking
    • 7.4.2.4. Strategic initiatives
  • 7.4.3. Koninklijke Philips N.V.
    • 7.4.3.1. Overview
    • 7.4.3.2. Financial performance
    • 7.4.3.3. Product benchmarking
    • 7.4.3.4. Strategic initiatives
  • 7.4.4. ResMed Inc.
    • 7.4.4.1. Overview
    • 7.4.4.2. Financial performance
    • 7.4.4.3. Product benchmarking
    • 7.4.4.4. Strategic initiatives
  • 7.4.5. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 7.4.5.1. Overview
    • 7.4.5.2. Financial performance
    • 7.4.5.3. Product benchmarking
    • 7.4.5.4. Strategic initiatives
  • 7.4.6. Masimo Corporation (Danaher)
    • 7.4.6.1. Overview
    • 7.4.6.2. Financial performance
    • 7.4.6.3. Product benchmarking
    • 7.4.6.4. Strategic initiatives
  • 7.4.7. Huma Therapeutics Limited
    • 7.4.7.1. Overview
    • 7.4.7.2. Financial performance
    • 7.4.7.3. Product benchmarking
    • 7.4.7.4. Strategic initiatives
  • 7.4.8. Doccla Limited
    • 7.4.8.1. Overview
    • 7.4.8.2. Financial performance
    • 7.4.8.3. Product benchmarking
    • 7.4.8.4. Strategic initiatives
  • 7.4.9. Biofourmis, Inc.
    • 7.4.9.1. Overview
    • 7.4.9.2. Financial performance
    • 7.4.9.3. Product benchmarking
    • 7.4.9.4. Strategic initiatives
  • 7.4.10. VitalConnect, Inc.( iRhythm Technologies)
    • 7.4.10.1. Overview
    • 7.4.10.2. Financial performance
    • 7.4.10.3. Product benchmarking
    • 7.4.10.4. Strategic initiatives
  • 7.4.11. VivaLNK, Inc
    • 7.4.11.1. Overview
    • 7.4.11.2. Financial performance
    • 7.4.11.3. Product benchmarking
    • 7.4.11.4. Strategic initiatives
  • 7.4.12. Fisher & Paykel Healthcare Limited
    • 7.4.12.1. Overview
    • 7.4.12.2. Financial performance
    • 7.4.12.3. Product benchmarking
    • 7.4.12.4. Strategic initiatives
  • 7.4.13. Breas Medical AB
    • 7.4.13.1. Overview
    • 7.4.13.2. Financial performance
    • 7.4.13.3. Product benchmarking
    • 7.4.13.4. Strategic initiatives
  • 7.4.14. Inogen, Inc.
    • 7.4.14.1. Overview
    • 7.4.14.2. Financial performance
    • 7.4.14.3. Product benchmarking
    • 7.4.14.4. Strategic initiatives
  • 7.4.15. BMC Medical Co., Ltd.
    • 7.4.15.1. Overview
    • 7.4.15.2. Financial performance
    • 7.4.15.3. Product benchmarking
    • 7.4.15.4. Strategic initiatives
  • 7.4.16. Drive|DeVilbiss Healthcare, Inc.
    • 7.4.16.1. Overview
    • 7.4.16.2. Financial performance
    • 7.4.16.3. Product benchmarking
    • 7.4.16.4. Strategic initiatives